0001750159-18-000001.txt : 20180815 0001750159-18-000001.hdr.sgml : 20180815 20180815140002 ACCESSION NUMBER: 0001750159-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180815 DATE AS OF CHANGE: 20180815 EFFECTIVENESS DATE: 20180815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genome Medical Holding Co CENTRAL INDEX KEY: 0001750159 IRS NUMBER: 813033508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-319314 FILM NUMBER: 181020562 BUSINESS ADDRESS: STREET 1: 95 THIRD STREET, SUITE 214 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 877.688.0992 MAIL ADDRESS: STREET 1: 95 THIRD STREET, SUITE 214 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 D 1 primary_doc.xml X0708 D LIVE 0001750159 Genome Medical Holding Co 95 THIRD STREET, SUITE 214 SAN FRANCISCO CA CALIFORNIA 94103 877.688.0992 DELAWARE Genome Medical, Inc. None Corporation true 2016 Lisa Alderson 95 Third Street #214 San Francisco CA CALIFORNIA 94013 Executive Officer Director Randal Scott 95 Third Street #214 San Francisco CA CALIFORNIA 94103 Director Robert Green 95 Third Street #214 San Francisco CA CALIFORNIA 94103 Director Tim Howe 95 Third Street #214 San Francisco CA CALIFORNIA 94103 Director Stephen Bloch 95 Third Street #214 San Francisco CA CALIFORNIA 94103 Director Nicholas Naclerio 95 Third Street #214 San Francisco CA CALIFORNIA 94103 Director Iana Dimkova 95 Third Street #214 San Francisco CA CALIFORNIA 94103 Director Other Technology Decline to Disclose 06b false 2018-05-31 false true false 0 223200 223200 0 Options granted pursuant to stockholder approved equity incentive plan; Total Offering Amount and Total Amount Sold based on option exercise price. false 1 0 0 0 false Genome Medical Holding Co /s/ Lisa J. Alderson Lisa J. Alderson Chief Executive Officer 2018-08-15